Advertisement
Screener

ASSERTIO THERAPEUTICS, INC. Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount

ASSERTIO THERAPEUTICS, INC. Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount

ASSERTIO THERAPEUTICS, INC. had Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount of $14.00 million as of 2018-12-31, per its 10-K filed 2019-03-11.

Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure

us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized · last filed 2019-03-11

  • 2018-12-31: Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount $14.00M.
  • 2018-06-30: Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount $13.20M.
  • 2018-03-31: Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount $19.40M.
  • 2017-12-31: Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount $22.90M.
Period endShare-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount
2018-12-31$14.00M
10-K · filed 2019-03-11
2018-06-30$13.20M
10-Q · filed 2018-08-08
2018-03-31$19.40M
10-Q · filed 2018-05-10
2017-12-31$22.90M
10-K · filed 2018-03-01
2017-09-30$25.40M
10-Q · filed 2017-11-09
2017-06-30$34.00M
10-Q · filed 2017-08-07
2017-03-31$36.20M
10-Q · filed 2017-05-10
2016-12-31$21.00M
10-K · filed 2017-02-24
2016-09-30$25.60M
10-Q · filed 2016-11-07
2016-06-30$28.30M
10-Q · filed 2016-08-03
2016-03-31$30.70M
10-Q · filed 2016-05-06
2015-09-30$22.70M
10-Q · filed 2015-11-09
2015-06-30$24.90M
10-Q · filed 2015-08-03
2015-03-31$22.90M
10-Q · filed 2015-05-11
2014-09-30$14.60M
10-Q · filed 2014-11-06
2014-06-30$15.00M
10-Q · filed 2014-08-06
2014-03-31$17.30M
10-Q · filed 2014-05-09
2013-09-30$10.60M
10-Q · filed 2013-11-07
2013-06-30$11.40M
10-Q · filed 2013-08-08
2013-03-31$12.50M
10-Q · filed 2013-05-09
2012-12-31$8.40M
10-K · filed 2013-02-22
2012-09-30$8.70M
10-Q · filed 2012-11-05
2012-06-30$7.60M
10-Q/A · filed 2012-08-13